Geode Capital Management, LLC Obs Eva Sa Transaction History

Geode Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	BUY	$2.47 - $3.34 $141,434 - $191,251	57,261 Added 229.36%	82,227 $255,000
Q1 2021 May 12, 2021	BUY	$2.01 - $5.05 $50,181 - $126,078	24,966 New	24,966 $81,000
Q4 2020 Feb 12, 2021	SELL	$1.89 - $2.55 $64,672 - $87,255	-34,218 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$1.87 - $4.47 $11,390 - $27,226	-6,091 Reduced 15.11%	34,218 $82,000
Q4 2019 Feb 13, 2020	BUY	$2.48 - $8.1 $49,701 - $162,332	20,041 Added 98.88%	40,309 $153,000

Q3 2019 Nov 12, 2019	SELL	$8.22 - $11.2 $1,446 - $1,971	-176 Reduced 0.86%	20,268 $168,000
Q2 2019 Aug 14, 2019	BUY	$10.05 - $14.25 $46,159 - $65,450	4,593 Added 28.98%	20,444 $231,000
Q1 2019 May 14, 2019	BUY	$11.82 - $14.48 $38,379 - $47,016	3,247 Added 25.76%	15,851 $202,000
Q4 2018 Feb 13, 2019	BUY	$10.8 - $17.94 $136,123 - $226,115	12,604 New	12,604 $159,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.